4.6 Review

Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention

Journal

CANCERS
Volume 13, Issue 7, Pages -

Publisher

MDPI
DOI: 10.3390/cancers13071513

Keywords

ubiquitin proteasome system; dysregulation; chemoresistance; cancer; therapy; inhibitors

Categories

Funding

  1. [R713-000-216-720]

Ask authors/readers for more resources

The UPS system regulates the non-lysosomal degradation of oxidized, damaged, or misfolded proteins through the activation and transfer of polyubiquitin chains to target proteins, which are then degraded by the 26S proteasome complex. UPS plays a crucial role in regulating protein levels to maintain fundamental cellular processes such as growth, division, signal transduction, and stress response. Dysregulation of UPS, resulting in loss of ability to maintain protein quality through proteolysis, is closely related to the development of various malignancies.
Simple Summary The ubiquitin proteasome system (UPS) governs the non-lysosomal degradation of oxidized, damaged, or misfolded proteins in eukaryotic cells. Dysregulation of the UPS results in loss of ability to maintain protein quality through proteolysis, and is closely related to the development of various malignancies and tumorigenesis. Here, we provide a comprehensive general overview on the regulation and roles of UPS and discuss the mechanisms linking dysregulated UPS to human malignancies. Inhibitors developed against components of the UPS, which include U.S. Food and Drug Administration FDA-approved and those currently undergoing clinical trials, are also presented in this review. The ubiquitin proteasome system (UPS) governs the non-lysosomal degradation of oxidized, damaged, or misfolded proteins in eukaryotic cells. This process is tightly regulated through the activation and transfer of polyubiquitin chains to target proteins which are then recognized and degraded by the 26S proteasome complex. The role of UPS is crucial in regulating protein levels through degradation to maintain fundamental cellular processes such as growth, division, signal transduction, and stress response. Dysregulation of the UPS, resulting in loss of ability to maintain protein quality through proteolysis, is closely related to the development of various malignancies and tumorigenesis. Here, we provide a comprehensive general overview on the regulation and roles of UPS and discuss functional links of dysregulated UPS in human malignancies. Inhibitors developed against components of the UPS, which include U.S. Food and Drug Administration FDA-approved and those currently undergoing clinical trials, are also presented in this review.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available